Cervical screening for women unprotected by HPV herd effect
Part of Cancer, Women’s health & pregnancy clinical trials.
This study checks how well cervical screening works for certain unvaccinated women depending on whether they are protected by “herd effect” from HPV vaccination in the community. It may help improve screening plans for women who may be at higher risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were born between 1995 and 1997
- You have lived for 25 years in one of the study communities
- Your community is classified as either “herd effect protected” or “no herd effect” based on local vaccination coverage
- You have not had immune system–weakening health conditions such as a transplant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests ways to improve cervical cancer screening for women ages 30–65. It may help catch cervical cancer early or prevent it entirely by finding precancerous changes.
This study looks at giving the HPV vaccine (Gardasil 9) to women while they go through Sweden’s routine HPV screening. It helps researchers understand how vaccine use alongside screening affects HPV infection and cervical cancer prevention.
This Phase 4 study tests whether a 9-type HPV vaccine (9vHPV) can reduce how infectious HPV is and lower the chance of HPV spreading in women who already have HPV16 and/or HPV18. It focuses on specific HPV-positive women recently diagnosed and compares what happens after vaccination.
This trial tests two cervical screening approaches to find early signs of HPV-related changes. It may help by improving how results are sorted into “needs follow-up” versus “routine care,” especially for women with different HPV patterns.
This trial tests a new, affordable way to screen for cervical cancer that can be done in low- and middle-income countries. It uses artificial intelligence to help decide who needs follow-up care.
This trial compares two ways to help women with HIV get screened for cervical cancer: a clinic-based approach versus a combined clinic and community outreach program. You may be able to provide samples yourself at a clinic or at home to test for HPV, the virus that can cause cervical cancer.
Hear when a new Cervical Intraepithelial Neoplasia Grade 2/3 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.